ExeVir Bio
DebtBelgiumJan 2023
ExeVir Bio raised €25M in a Debt round in Jan 2023. The company is based in Belgium. Investors in the round: European Investment Bank. Data as of Nov 2026.
Amount raised
€25M
€25,000,000
Native amount
25,000,000 EUR
Stage
Debt
debt
Investors
1
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €25M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyThis is the company's only recorded round.
Related news
- Belgium’s ExeVir raises €25M from EIB to develop novel COVID-19 therapeuticsiliconcanals.com · 2023-01